| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.3M | -32.6% |
| Cost of Revenue | $1.5M | -91.9% |
| Gross Profit | $1.8M | +113.3% |
| R&D Expense | $3.2M | -73.4% |
| SG&A Expense | $14.3M | -55.9% |
| Operating Income | -$18.4M | +73.9% |
| Pre-tax Income | -$30.1M | +57.5% |
| Income Tax | -$55K | -107.6% |
| Net Income | -$41.0M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $381K | -89.3% |
| Accounts Receivable | $962K | +403.7% |
| Inventory | $8K | -99.7% |
| Current Assets | $2.7M | -69.5% |
| Total Assets | $8.0M | -76.9% |
| Current Liabilities | $28.8M | +141.5% |
| Total Liabilities | $29.3M | +37.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.4M | +104.4% |
| Investing Cash Flow | $1.2M | +119.4% |
| Financing Cash Flow | $850K | -90.6% |
| +42.6% |
| EPS (Basic) | -$15.65 | +58.0% |
| EPS (Diluted) | -$15.65 | +58.0% |
| Stockholders' Equity |
| -$21.3M |
| -258.4% |